Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Journal of Animal Science|September 26, 2014
The genome-wide structure of two economically important indigenous Sicilian cattle breedsS Mastrangelo, M Saura, M Tolone, et al.
Haematologica|November 24, 1998
Ex vivo expansion of hematopoietic cells and their clinical useM Aglietta, F Bertolini, C Carlo-Stella, et al.
Bone Marrow Transplantation|December 1, 1996
Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in childrenF Locatelli, R Maccario, P Comoli, et al.
Haematologica|March 1, 1997
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspectsF Bertolini, A de Vincentiis, L Lanata, et al.
Animal Genetics|June 15, 2016
Genome-wide association study for the level of serum electrolytes in Italian Large White pigsS Bovo, G Schiavo, G Mazzoni, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
British Journal of Cancer|September 16, 2010
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapyC Bengala, S Bettelli, F Bertolini, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 6, 2020
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost AnalysisD Laszlo, G P Marcacci, M Martino, et al.
Leukemia Research|August 4, 2009
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and RituximabC Rabascio, D Laszlo, G Andreola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Pageof 19